{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:45:47Z","timestamp":1789577147210,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20730-2","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:28:06Z","timestamp":1761038886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral cytokine levels in patients with idiopathic parkinson\u2019s disease undergoing subthalamic nucleus deep brain stimulation"],"prefix":"10.1038","volume":"15","author":[{"given":"Ersoy","family":"Kocab\u0131cak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafize","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Onur","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dursun","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20730_CR1","doi-asserted-by":"publisher","first-page":"114645","DOI":"10.1016\/j.expneurol.2023.114645","volume":"373","author":"K Rademacher","year":"2024","unstructured":"Rademacher, K. & Nakamura, K. Role of dopamine neuron activity in Parkinson\u2019s disease pathophysiology. Exp. Neurol. 373, 114645 (2024).","journal-title":"Exp. Neurol."},{"key":"20730_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fnins.2020.00492","volume":"14","author":"M Porta","year":"2020","unstructured":"Porta, M., Servello, D., Zekaj, E., Gonzalez-Escamilla, G. & Groppa, S. Pre-dopa deep brain stimulation: Is early deep brain stimulation able to modify the natural course of Parkinson\u2019s disease?. Front Neurosci. 14, 492 (2020).","journal-title":"Front Neurosci."},{"key":"20730_CR3","first-page":"175","volume":"149","author":"P Pollak","year":"1993","unstructured":"Pollak, P. et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev. Neurol. 149, 175\u2013176 (1993).","journal-title":"Rev. Neurol."},{"issue":"11","key":"20730_CR4","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.clineuro.2013.08.020","volume":"115","author":"E Kocabicak","year":"2013","unstructured":"Kocabicak, E. & Temel, Y. Deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease: Surgical technique, tips, tricks and complications. Clin. Neurol. Neurosurg. 115(11), 2318\u20132323 (2013).","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"20730_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17434440.2025.2480660","volume":"22","author":"A Lawson McLean","year":"2025","unstructured":"Lawson McLean, A. & Nemir, J. Quantifying insertional effects in deep brain stimulation: Clinical outcomes and neurophysiological mechanisms. Expert Rev. Med. Devices. 22(4), 285\u2013291 (2025).","journal-title":"Expert Rev. Med. Devices."},{"issue":"3","key":"20730_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000343808","volume":"97","author":"C Seifried","year":"2013","unstructured":"Seifried, C. et al. Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson\u2019s disease. Neuroendocrinology 97(3), 283\u2013290 (2013).","journal-title":"Neuroendocrinology"},{"key":"20730_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-015-0384-7","volume":"12","author":"BO Amorim","year":"2015","unstructured":"Amorim, B. O. et al. Deep brain stimulation induces antiapoptotic and anti-inflammatory effects in epileptic rats. J. Neuroinflam. 12, 162 (2015).","journal-title":"J. Neuroinflam."},{"issue":"235\u2013259","key":"20730_CR8","first-page":"3","volume":"175","author":"D Mukhara","year":"2020","unstructured":"Mukhara, D., Oh, U. & Neigh, G. N. Neuroinflammation. Handb. Clin. Neurol. 175(235\u2013259), 3 (2020).","journal-title":"Handb. Clin. Neurol."},{"issue":"11","key":"20730_CR9","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.3390\/ijms24119647","volume":"24","author":"JL Wautier","year":"2023","unstructured":"Wautier, J. L. & Wautier, M. P. Pro- and anti-inflammatory prostaglandins and cytokines in humans: A mini review. Int. J. Mol. Sci. 24(11), 9647 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"20730_CR10","doi-asserted-by":"publisher","first-page":"636139","DOI":"10.3389\/fneur.2021.636139","volume":"12","author":"AF Magnusen","year":"2021","unstructured":"Magnusen, A. F., Hatton, S. L., Rani, R. & Pandey, M. K. Genetic defects and pro-inflammatory cytokines in Parkinson\u2019s disease. Front. Neurol. 12, 636139 (2021).","journal-title":"Front. Neurol."},{"issue":"1","key":"20730_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41531-024-00784-1","volume":"10","author":"KA Woo","year":"2024","unstructured":"Woo, K. A. et al. Parkinson\u2019s disease is associated with clonal hematopoiesis with TET2 mutation. NPJ. Parkinsons Dis. 10(1), 168 (2024).","journal-title":"NPJ. Parkinsons Dis."},{"key":"20730_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbi.2020.07.035","volume":"90","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Subthalamic nucleus deep brain stimulation suppresses neuroinflammation by Fractalkine pathway in Parkinson\u2019s disease rat model. Brain Behav. Immun. 90, 16\u201325 (2020).","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"20730_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-019-00784-3","volume":"40","author":"ACP Campos","year":"2020","unstructured":"Campos, A. C. P. et al. Unraveling the role of astrocytes in subthalamic nucleus deep brain stimulation in a Parkinson\u2019s disease rat model. Cell Mol. Neurobiol. 40(6), 939\u2013954 (2020).","journal-title":"Cell Mol. Neurobiol."},{"issue":"2","key":"20730_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11481-020-09934-7","volume":"16","author":"B Grembecka","year":"2021","unstructured":"Grembecka, B. et al. Subthalamic deep brain stimulation affects plasma corticosterone concentration and peripheral immunity changes in rat model of Parkinson\u2019s disease. J. Neuroimmune Pharmacol. 16(2), 454\u2013469 (2021).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"12","key":"20730_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"J Jankovic","year":"2015","unstructured":"Jankovic, J. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30(12), 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"issue":"10","key":"20730_CR16","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma, R. B. et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 33(10), 1601\u20131608 (2018).","journal-title":"Mov. Disord."},{"issue":"8","key":"20730_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","volume":"266","author":"A Regnault","year":"2019","unstructured":"Regnault, A. et al. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson\u2019s disease? Learnings from the Parkinson\u2019s progression marker initiative cohort. J Neurol. 266(8), 1927\u20131936 (2019).","journal-title":"J Neurol."},{"issue":"2","key":"20730_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/THC-151124","volume":"24","author":"A Ko\u00e7er","year":"2016","unstructured":"Ko\u00e7er, A. & Oktay, A. B. Nintendo Wii assessment of Hoehn and Yahr score with Parkinson\u2019s disease tremor. Technol Health Care. 24(2), 185\u2013191 (2016).","journal-title":"Technol Health Care."},{"key":"20730_CR19","doi-asserted-by":"publisher","first-page":"106371","DOI":"10.1016\/j.nbd.2023.106371","volume":"190","author":"G Di Lazzaro","year":"2024","unstructured":"Di Lazzaro, G. et al. Differential profiles of serum cytokines in Parkinson\u2019s disease according to disease duration. Neurobiol. Dis. 190, 106371 (2024).","journal-title":"Neurobiol. Dis."},{"key":"20730_CR20","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.bbih.2022.100442","volume":"21","author":"K Diaz","year":"2022","unstructured":"Diaz, K., Kohut, M. L., Russell, D. W. & Stegem\u00f6ller, E. L. Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson\u2019s disease. Brain Behav. Immun. Health. 21, 100442 (2022).","journal-title":"Brain Behav. Immun. Health."},{"issue":"1","key":"20730_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41531-023-00559-0","volume":"9","author":"SS Jiang","year":"2023","unstructured":"Jiang, S. S. et al. Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9(1), 117 (2023).","journal-title":"NPJ Parkinsons Dis."},{"issue":"4","key":"20730_CR22","doi-asserted-by":"publisher","first-page":"e20220063","DOI":"10.1042\/NS20220063","volume":"7","author":"N Dzamko","year":"2023","unstructured":"Dzamko, N. Cytokine activity in Parkinson\u2019s disease. Neuronal Signal. 7(4), e20220063 (2023).","journal-title":"Neuronal Signal."},{"key":"20730_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchemneu.2017.03.003","volume":"87","author":"M Terzi","year":"2018","unstructured":"Terzi, M. et al. The use of non-steroidal anti-inflammatory drugs in neurological diseases. J. Chem. Neuroanat. 87, 12\u201324 (2018).","journal-title":"J. Chem. Neuroanat."},{"key":"20730_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mdc3.13348","volume":"9","author":"S Bjerknes","year":"2022","unstructured":"Bjerknes, S. et al. Subthalamic nucleus stimulation in Parkinson\u2019s disease: 5-year extension study of a randomized trial. Mov. Disord. Clin. Pract. 9, 48\u201359 (2022).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"20730_CR25","doi-asserted-by":"publisher","first-page":"120484","DOI":"10.1016\/j.jns.2022.120484","volume":"444","author":"YS Hwang","year":"2023","unstructured":"Hwang, Y. S. et al. Long-term motor outcomes of deep brain stimulation of the globus pallidus interna in Parkinson\u2019s disease patients: Five-year follow-up. J. Neurol. Sci. 444, 120484 (2023).","journal-title":"J. Neurol. Sci."},{"key":"20730_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.nicl.2018.05.006","volume":"19","author":"K Mueller","year":"2018","unstructured":"Mueller, K. et al. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson\u2019s disease. Neuroimage Clin. 19, 1025\u20131035 (2018).","journal-title":"Neuroimage Clin."},{"issue":"7","key":"20730_CR27","doi-asserted-by":"publisher","first-page":"e0159340","DOI":"10.1371\/journal.pone.0159340","volume":"11","author":"T Fundament","year":"2016","unstructured":"Fundament, T. et al. Deep brain stimulation for parkinson\u2019s disease with early motor complications: A UK cost-effectiveness analysis. PLoS ONE 11(7), e0159340 (2016).","journal-title":"PLoS ONE"},{"issue":"8","key":"20730_CR28","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/cns.14167","volume":"29","author":"L Chang","year":"2023","unstructured":"Chang, L. et al. Deep brain stimulation improves central nervous system inflammation in Parkinson\u2019s disease: Evidence and perspectives. CNS Neurosci. Ther. 29(8), 2177\u20132185 (2023).","journal-title":"CNS Neurosci. Ther."},{"issue":"Suppl 4","key":"20730_CR29","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.4103\/2152-7806.103024","volume":"3","author":"E Kocabicak","year":"2012","unstructured":"Kocabicak, E., Tan, S. K. & Temel, Y. Deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease: Why so successful?. Surg. Neurol. Int. 3(Suppl 4), S312\u2013S314 (2012).","journal-title":"Surg. Neurol. Int."},{"issue":"3","key":"20730_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1474-4422(18)30035-8","volume":"17","author":"E Lhomm\u00e9e","year":"2018","unstructured":"Lhomm\u00e9e, E. et al. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson\u2019s disease with early motor complications (EARLYSTIM trial): Secondary analysis of an open-label randomised trial. Lancet Neurol. 17(3), 223\u2013231 (2018).","journal-title":"Lancet Neurol."},{"issue":"8","key":"20730_CR31","doi-asserted-by":"publisher","first-page":"e3172","DOI":"10.1002\/brb3.3172","volume":"13","author":"G Luo","year":"2023","unstructured":"Luo, G. et al. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson\u2019s disease. Brain Behav. 13(8), e3172 (2023).","journal-title":"Brain Behav."},{"issue":"3","key":"20730_CR32","first-page":"430","volume":"29","author":"D Aygun","year":"2019","unstructured":"Aygun, D., Dere, U. A., Yildiz, O., Temel, Y. & Kocabicak, E. Characterizing the intraoperative microelectrode recording-induced microlesion effect on motor symptoms in patients with Parkinson\u2019s disease undergoing deep brain stimulation of the subthalamic nucleus. Turk. Neurosurg. 29(3), 430\u2013433 (2019).","journal-title":"Turk. Neurosurg."},{"issue":"1","key":"20730_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3171\/2023.11.JNS232164","volume":"141","author":"JW Chen","year":"2024","unstructured":"Chen, J. W. et al. Electrode position and cognitive outcome following deep brain stimulation surgery. J. Neurosurg. 141(1), 230\u2013240 (2024).","journal-title":"J. Neurosurg."},{"issue":"43","key":"20730_CR34","doi-asserted-by":"publisher","first-page":"17087","DOI":"10.1073\/pnas.0704144104","volume":"104","author":"Y Temel","year":"2007","unstructured":"Temel, Y. et al. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc. Natl. Acad. Sci. U. S. A. 104(43), 17087\u201317092 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"20730_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2011.08.027","volume":"233","author":"SK Tan","year":"2012","unstructured":"Tan, S. K. et al. A combined in vivo neurochemical and electro- physiological analysis of the effect of high- frequency stimulation of the subthalamic nucleus on 5-HT transmission. Exp Neurol. 233, 145\u2013153 (2012).","journal-title":"Exp Neurol."},{"issue":"3","key":"20730_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","volume":"61","author":"SK Tan","year":"2011","unstructured":"Tan, S. K., Hartung, H., Sharp, T. & Temel, Y. Serotonin-dependent depression in Parkinson\u2019s disease: A role for the subthalamic nucleus?. Neuropharmacology 61(3), 387\u2013399 (2011).","journal-title":"Neuropharmacology"},{"key":"20730_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70160","author":"J Steinhardt","year":"2025","unstructured":"Steinhardt, J. et al. The impact of deep brain stimulation of the subthalamic nucleus on sleep-wake function and circadian rhythms in patients with Parkinson\u2019s disease. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70160 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"20730_CR38","doi-asserted-by":"publisher","first-page":"698634","DOI":"10.1155\/2013\/698634","volume":"2013","author":"JM Calleja-Castillo","year":"2013","unstructured":"Calleja-Castillo, J. M. et al. Chronic deep brain stimulation of the hypothalamic nucleus in wistar rats alters circulatory levels of corticosterone and proinflammatory cytokines. Clin. Dev. Immunol. 2013, 698634 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"20730_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2011.00077","volume":"2","author":"PL McGeer","year":"2011","unstructured":"McGeer, P. L. & McGeer, E. G. History of innate immunity in neurodegenerative disorders. Front. Pharmacol. 2, 77 (2011).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"20730_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5603\/PJNNS.a2023.0044","volume":"57","author":"P Alster","year":"2023","unstructured":"Alster, P. et al. Role of orexin in pathogenesis of neurodegenerative parkinsonisms. Neurol Neurochir. Pol. 57(4), 335\u2013343 (2023).","journal-title":"Neurol Neurochir. Pol."},{"issue":"9","key":"20730_CR41","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3390\/ijms20092341","volume":"20","author":"MK Schuhmann","year":"2019","unstructured":"Schuhmann, M. K., Stoll, G., Bohr, A., Volkmann, J. & Fluri, F. Electrical stimulation of the mesencephalic locomotor region attenuates neuronal loss and cytokine expression in the perifocal region of photothrombotic stroke in rats. Int. J. Mol. Sci. 20(9), 2341 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"20730_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale, M. et al. Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav. Immun. 23(1), 55\u201363 (2009).","journal-title":"Brain Behav. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20730-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20730-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20730-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:09Z","timestamp":1761041049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20730-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20730"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20730-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the Helsinki declaration. Approval for this study was granted by Ondokuz May\u0131s University, Faculty of Medicine Ethics Committee for Clinical Studies (Approval date: 29.04.2016; Number: B.30.ODM.0.20.08\/260).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent has been obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"36719"}}